Curateq Biologics s.r.o., a wholly owned step-down subsidiary of the company, has obtained marketing authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) for Bevgolva, its bevacizumab biosimilar version. Bevacizumab is used in the treatment of multiple cancers, including metastatic colorectal cancer.
The company has acquired 59.7 lakh equity shares (representing 7.6% equity) in its subsidiary Agilus Diagnostics from the International Finance Corporation at a price of Rs 719.2 per share, for Rs 429.37 crore.
Investors Eight Roads Ventures and F-Prime Capital have together invested Rs 120 crore in Laurus Bio, a subsidiary company of Laurus Labs. The company completed the said transaction on December 20.
The Competition Commission of India (CCI) has approved the acquisition of I ndia Cements by UltraTech Cement. UltraTech will acquire 10.13 crore equity shares (32.72% equity stake) held by the promoters and the other shareholder in India Cements and will make an open offer for up to 8.05 crore equity shares (26% equity) in India Cements at a price of Rs 390 per share from the public shareholders.
The company has announced the execution of a definitive agreement with TSR Darashaw HR Services. The company also announced the availing of board approval to acquire a stake in Crystal HR and Security Solutions (Crystal HR). TeamLease will acquire a 90% stake in TSR Darashaw and a 30% stake in Crystal HR and Security. Post-acquisition, TSR Darashaw will be a subsidiary of the company, and Crystal HR will be an associate of the company.
The company's subsidiary Tata Consultancy Services (Africa) (Proprietary) (TCS Africa) has entered into an agreement with Isisekelo Sethu Trust to sell and dispose of its 30% shares in TCS SA to comply with the Broad-Based Black Economic Empowerment (B-BBEE) guidelines in South Africa. Post the transaction, TCS SA will cease to be a wholly owned step-down subsidiary of TCS. TCS Africa is a wholly owned subsidiary, and Tata Consultancy Services (South Africa) (Proprietary) (TCS SA) is a step-down wholly owned subsidiary of Tata Consultancy Services.
The company's subsidiary Reliance Digital Health has entered into definitive agreements to acquire a 45% equity stake in Health Alliance Group Inc. for $10 million. HAGI is a US-based healthcare company specializing in designing technology-driven solutions for the underserved in the United States, India, and the rest of the world.
The company has signed a Memorandum of Understanding (MoU) with the Bihar government to establish renewable energy projects in Bihar.
Rajiv Bansal has resigned from the post of President & Chief Transformation Officer of the company to pursue other opportunities outside the company.
Vedanta will not carve out a separate listed unit for its base metals business. It will consider the base metals business demerger at a later stage, while the share entitlement ratio for the demerger of the remaining five businesses would remain unchanged.
The Board has approved the public issuance of secured non-convertible debentures (NCDs) of face value Rs 1,000 each, amounting up to Rs 2,000 crore in one or more tranches.
The Board has approved the appointment of Darshil Shah as the Managing Director of the company in place of Hitesh Shah for five years, effective January 1, 2025. Currently, Darshil Shah is the Executive Director. The Board also changed the designation of Hitesh Shah from Managing Director to Non-Executive Director of the company.
In line with HCC's strategy to focus on its core EPC operations, HCC's stake in Steiner AG (SAG), held via wholly owned subsidiaries HCC Mauritius and HCC Mauritius Enterprises, has been sold to Uniresolv SA, an affiliate of m3 immobilier Holding SA (m3), a prominent player in Geneva's real estate and finance sectors.
The Board has approved the company's fund raising of up to Rs 1,500 crore via preferential issue, private placement, rights issue, public issue, qualified institutional placement, or other modes.
The Board has approved an investment of Rs 657.33 crore for setting up a yarn project at Bhadrak, Odisha. The project, which is a 50:50 joint venture with MCPI, consists of a 900 TPD continuous polymerization (CP) unit with downstream units of draw textured yarn (DTY), fully drawn yarn (FDY), polyester chips, and associated facilities, with an estimated cost of Rs 4,382.21 crore.
Vikasdhan - Grow your Dhan with Vikasdhan
Disclaimer- not an investment advice, only for educational purpose. Read full disclaimer https://vikasdhan.com/disclaimer